<Anchor>



Pfizer, an American pharmaceutical company, predicted that the effect of the booster dose of the corona vaccine would be maintained for one year. At the same time, it is known that Pfizer will apply to the U.S. Food and Drug Administration to expand the vaccination list to all adults. 



Correspondent Kim Jong-won from New York.



<Reporter>



American pharmaceutical company Pfizer said that the booster shot, a booster dose of the corona vaccine, is more effective than the first two doses.



[Albert Bulla/Pfizer CEO: The third booster dose, 'Booster Shot', showed a very, very high level of preventive effect. The effectiveness is higher than the first two doses, which are 95% effective.] The



key is how long this effect lasts, and Pfizer CEO Albert Bulla said the validity of a single booster dose will not be known until several months later. Based on the data of



[Albert Bulla / Pfizer CEO: The effect of the vaccine booster shot seems to be maintained for one year. From now on, you will be vaccinated once a year.] The 



US media said that Pfizer will apply to US health authorities, such as the US Food and Drug Administration and FDA, to expand the corona booster shot to all adults by the 10th. reported.



Currently, Pfizer BoosterShot is approved only for seniors 65 years of age or older or those at high risk of Corona.



The New York Times reports that the FDA is likely to approve Pfizer's application before Thanksgiving on the 25th.



The FDA's external advisory body said in September that it opposes vaccination for all adults while reviewing whether to approve the use of BoosterShot.